Results 1 - 10 of 185
Researchers
Explore mentor profiles by selecting a name below. Each profile includes information about research interests, lab affiliations, publications, and additional details about their work and expertise.
| Name | Track | Location | View profile |
|---|---|---|---|
| Biochemistry and Molecular Biology, Immunology, Molecular Pharmacology and Experimental Therapeutics, Neuroscience, Virology and Gene Therapy | Minnesota | ||
Introduction
Aaron J. Johnson, Ph.D., is interested in neuroimmunology, with a major emphasis on the role of CD8 T cells and the pore-forming molecule perforin on blood-brain barrier (BBB) disruption. Despite the enormous burden of morbidity and mortality due to neurological diseases associated with central nervous system vascular permeability, the underlying molecular mechanisms of how inflammatory cells promote BBB disruption remain poorly understood. To understand the mechanism of immune-mediated BBB disruption, Dr. Johnson employs both virus and cerebral malaria mouse models. He has also incorporated preclinical models of glioblastoma multiforme and brain atrophy into his research program.
|
|||
| Biomedical Engineering and Physiology | Minnesota | ||
IntroductionDr. Abhishek Chandra is a faculty researcher whose work focuses on mechanisms of bone loss due to aging, disease, and radiotherapy. His research explores cellular processes such as DNA damage, senescence, and stem cell fate that influence bone health. He aims to develop therapies to prevent osteoporosis, improve fracture healing, and enhance bone quality, particularly after radiation exposure. As a mentor, he fosters interdisciplinary, translational research and supports trainee development in scientific innovation and career growth. |
|||
| Biochemistry and Molecular Biology, Molecular Pharmacology and Experimental Therapeutics | Florida | ||
IntroductionI have passionately helped individuals develop into independent scientific investigators and champions of science for more than 20 years. As a mentor of students and trainees in independent research, I seek to make a contribution to the development of the whole person. This requires that I understand mentee current intellectual and professional states as well as future plans. Each person I mentor is different, and different goals require different skills, but I will aspire to help mentee develop certain universal skills — asking questions, identifying good research projects and questions, managing projects, etc. I will encourage mentee to be a good team player and have the courage to lead when leadership is needed. |
|||
| Biochemistry and Molecular Biology, Clinical and Translational Science, Immunology, Virology and Gene Therapy | Minnesota | ||
IntroductionMy scientific interest throughout my career has been in intracellular signaling, with a particular focus on pathways involved in programmed cell death. We aim not only to understand the core death-signaling apparatus but to also understand how multiple other inputs from concurrent signaling responses integrate with it. This integration of multiple signaling pathways determines whether a cell dies or survives, and is therefore central to how T cells eliminate infected cells. It is also central to why T cells are poor at killing most tumor cells. |
|||
| Neuroscience, Regenerative Science | Minnesota | ||
IntroductionDr. Ahad M. Siddiqui is an Assistant Professor of Neurology and Regenerative Medicine at Mayo Clinic whose research focuses on regenerative neuroimmunology and neural repair following spinal cord injury. His laboratory integrates biomaterials engineering, cell and gene therapies, extracellular vesicle technologies, neuromodulation, and AI-driven imaging analysis to develop innovative strategies for restoring function after neurological injury. Graduate students in Dr. Siddiqui’s lab gain interdisciplinary training at the intersection of neuroscience, bioengineering, and translational medicine while contributing to research aimed at advancing next-generation therapies for patients with paralysis and other nervous system injuries. |
|||
| Clinical and Translational Science | Minnesota | ||
IntroductionDr. Denic is an Associate Consultant 2, and an Associate Professor in Medicine in the Division of Nephrology and Hypertension. He has 110 publications, and more than 5,000 citations. Dr. Denic is focused on understanding how kidney histology and macrostructure are associated with chronic kidney conditions and allograft loss in kidney transplant recipients. He uses kidney biopsies, computerized tomography scans to pursue these studies. More recently Dr. Denic became interested in applying artificial intelligence methods to quantify histological and macrostructural metrics of kidney and visceral obesity. He has received a funding from NIH to assess how various AI-based macrostructural kidney metrics associate with chronic kidney disease. |
|||
| Biomedical Engineering and Physiology, Regenerative Science | Minnesota | ||
IntroductionDr. Matveyenko’s professional career centers on basic and translational research in the pathophysiology of diabetes mellitus, with a particular focus on the role of pancreatic beta-cell failure in the development of diabetes and related metabolic diseases. The laboratory employs an integrative research strategy, spanning cellular, molecular, and biochemical analyses as well as in vivo physiological studies using genetic and environmental rodent models of diabetes and obesity. The laboratory receives substantial funding from NIH/NIDDK and has published extensively on circadian biology and physiology, molecular regulation of insulin secretion, and metabolic control of beta cell function and turnover. |
|||
| Biochemistry and Molecular Biology, Molecular Pharmacology and Experimental Therapeutics, Regenerative Science | Minnesota | ||
IntroductionThe Laboratory of Functional Epigenomics has been working on various aspects of transcription and enhancer regulation with implications in cellular heterogeneity and drug resistance in ovarian, breast and endometrial cancers. The goal of the lab is to use epigenomic profiling to better understand cancer programs associated with malignancy, metastasis, drug sensitivity and define transcriptional dependencies. |
|||
| Biochemistry and Molecular Biology, Molecular Pharmacology and Experimental Therapeutics, Regenerative Science | Minnesota | ||
Introduction
My group has been working on various aspects of transcription and enhancer regulation with implications for cellular heterogeneity, malignant transformation and reprogramming.
|
|||
| Biochemistry and Molecular Biology | Minnesota | ||
IntroductionMy lab uses computational genomics to understand how the human genome changes across cells during development, aging, and disease. We use naturally occurring mutations as markers of cell ancestry to reconstruct human cell lineages and explore the earliest stages of human development. We also study somatic mosaicism and its roles in aging, cancer, and neurodevelopmental disorders. Our work combines whole-genome, single-cell, and multi-omics data with development of new computational methods. I mentor trainees to pursue ambitious questions, develop independent scientific thinking and strong quantitative skills, and build projects that connect methodological innovation with fundamental questions in human biology and disease. |
|||